Sensitivity and Specificity of the NETest: A Validation Study

Conclusions: The sensitivity of the NETest is exceptionally high (>95%) in a population of metastatic, well-differentiated NETs. Specificity within a healthy population of patients is exceptionally high when using a normal range of 0-20% but relatively low when evaluating patients with other GI malignancies.
Source: Neuroendocrinology - Category: Endocrinology Source Type: research